Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 139

1.

Oxygen Disrupts Human Fetal Lung Mesenchymal Cells: Implications for Bronchopulmonary Dysplasia.

Möbius MA, Freund D, Vadivel A, Koss S, McConaghy S, Ohls RK, Rüdiger M, Thébaud B.

Am J Respir Cell Mol Biol. 2018 Dec 18. doi: 10.1165/rcmb.2018-0358OC. [Epub ahead of print]

PMID:
30562051
2.

Endothelial colony-forming cell therapy for heart morphological changes after neonatal high oxygen exposure in rats, a model of complications of prematurity.

Girard-Bock C, de Araújo CC, Bertagnolli M, Mai-Vo TA, Vadivel A, Alphonse RS, Zhong S, Cloutier A, Sutherland MR, Thébaud B, Nuyt AM.

Physiol Rep. 2018 Nov;6(22):e13922. doi: 10.14814/phy2.13922.

3.

Preventing bronchopulmonary dysplasia: new tools for an old challenge.

Álvarez-Fuente M, Moreno L, Mitchell JA, Reiss IK, Lopez P, Elorza D, Duijts L, Avila-Alvarez A, Arruza L, Ramirez Orellana M, Baraldi E, Zaramella P, Rueda S, Gimeno-Díaz de Atauri Á, Guimarães H, Rocha G, Proença E, Thébaud B, Del Cerro MJ.

Pediatr Res. 2018 Nov 21. doi: 10.1038/s41390-018-0228-0. [Epub ahead of print] Review.

PMID:
30464331
4.

Target oxygen saturation and development of pulmonary hypertension and increased pulmonary vascular resistance in preterm infants.

Laliberté C, Hanna Y, Fadel NB, Lemyre B, Bijelic V, Barrowman N, Hoey L, Thébaud B, Katz SL.

Pediatr Pulmonol. 2019 Jan;54(1):73-81. doi: 10.1002/ppul.24193. Epub 2018 Nov 20.

PMID:
30461218
5.

Nanotherapies for micropreemies: Stem cells and the secretome in bronchopulmonary dysplasia.

Lesage F, Thébaud B.

Semin Perinatol. 2018 Nov;42(7):453-458. doi: 10.1053/j.semperi.2018.09.007. Epub 2018 Oct 6. Review.

PMID:
30376986
6.

Cell-based therapy for bronchopulmonary dysplasia in preterm infants 1.

Guillot M, Offringa M, Lacaze-Masmonteil T, Thébaud B.

Can J Physiol Pharmacol. 2018 Oct 5:1-3. doi: 10.1139/cjpp-2018-0342. [Epub ahead of print]

PMID:
30290122
7.

The Therapeutic Potential of Stem Cells for Bronchopulmonary Dysplasia: "It's About Time" or "Not so Fast" ?

Ee MT, Thébaud B.

Curr Pediatr Rev. 2018;14(4):227-238. doi: 10.2174/1573396314666180911100503. Review.

PMID:
30205800
8.

Endothelial Colony-Forming Cells in Young Adults Born Preterm: A Novel Link Between Neonatal Complications and Adult Risks for Cardiovascular Disease.

Bertagnolli M, Xie LF, Paquette K, He Y, Cloutier A, Fernandes RO, Béland C, Sutherland MR, Delfrate J, Curnier D, Bigras JL, Rivard A, Thébaud B, Luu TM, Nuyt AM.

J Am Heart Assoc. 2018 Jul 9;7(14). pii: e009720. doi: 10.1161/JAHA.118.009720.

9.

Stem cell-based therapies in neonatology: a new hope.

Thébaud B.

Arch Dis Child Fetal Neonatal Ed. 2018 Nov;103(6):F583-F588. doi: 10.1136/archdischild-2017-314451. Epub 2018 Jul 4. Review.

PMID:
29973349
10.

Impaired Angiogenic Supportive Capacity and Altered Gene Expression Profile of Resident CD146+ Mesenchymal Stromal Cells Isolated from Hyperoxia-Injured Neonatal Rat Lungs.

Collins JJP, Lithopoulos MA, Dos Santos CC, Issa N, Möbius MA, Ito C, Zhong S, Vadivel A, Thébaud B.

Stem Cells Dev. 2018 Aug 15;27(16):1109-1124. doi: 10.1089/scd.2017.0145. Epub 2018 Jun 29.

PMID:
29957134
11.

Mesenchymal Stromal Cell Therapy for Respiratory Complications of Extreme Prematurity.

Thébaud B.

Am J Perinatol. 2018 May;35(6):566-569. doi: 10.1055/s-0038-1639371. Epub 2018 Apr 25.

PMID:
29694998
12.

Bronchopulmonary Dysplasia: Executive Summary of a Workshop.

Higgins RD, Jobe AH, Koso-Thomas M, Bancalari E, Viscardi RM, Hartert TV, Ryan RM, Kallapur SG, Steinhorn RH, Konduri GG, Davis SD, Thebaud B, Clyman RI, Collaco JM, Martin CR, Woods JC, Finer NN, Raju TNK.

J Pediatr. 2018 Jun;197:300-308. doi: 10.1016/j.jpeds.2018.01.043. Epub 2018 Mar 16. No abstract available.

PMID:
29551318
13.

Long-term follow-up of cardiorespiratory outcomes in children born extremely preterm: Recommendations from a Canadian consensus workshop.

Katz SL, Luu TM, Nuyt AM, Lacaze T, Adamo KB, Adatia I, Humpl T, Jankov RP, Moraes TJ, Staub K, Stickland MK, Thebaud B; Long-term Cardio-Respiratory Outcomes of Extremely Preterm Infants Working Group.

Paediatr Child Health. 2017 May;22(2):75-79. doi: 10.1093/pch/pxx028. Epub 2017 Apr 17. Review.

14.

Novel therapeutics for bronchopulmonary dysplasia.

Strueby L, Thébaud B.

Curr Opin Pediatr. 2018 Jun;30(3):378-383. doi: 10.1097/MOP.0000000000000613. Review.

PMID:
29465463
15.

Mesenchymal stem cells for the prevention and treatment of bronchopulmonary dysplasia in preterm infants.

Pierro M, Thébaud B, Soll R.

Cochrane Database Syst Rev. 2017 Nov 10;11:CD011932. doi: 10.1002/14651858.CD011932.pub2. Review.

PMID:
29125893
16.

Human induced pluripotent stem cell-derived lung progenitor and alveolar epithelial cells attenuate hyperoxia-induced lung injury.

Shafa M, Ionescu LI, Vadivel A, Collins JJP, Xu L, Zhong S, Kang M, de Caen G, Daneshmand M, Shi J, Fu KZ, Qi A, Wang Y, Ellis J, Stanford WL, Thébaud B.

Cytotherapy. 2018 Jan;20(1):108-125. doi: 10.1016/j.jcyt.2017.09.003. Epub 2017 Oct 20.

PMID:
29056548
17.

Mesenchymal Stromal Cell Therapy in Bronchopulmonary Dysplasia: Systematic Review and Meta-Analysis of Preclinical Studies.

Augustine S, Avey MT, Harrison B, Locke T, Ghannad M, Moher D, Thébaud B.

Stem Cells Transl Med. 2017 Dec;6(12):2079-2093. doi: 10.1002/sctm.17-0126. Epub 2017 Oct 17.

18.

Can We Cure Bronchopulmonary Dysplasia?

Thébaud B, Kourembanas S.

J Pediatr. 2017 Dec;191:12-14. doi: 10.1016/j.jpeds.2017.07.028. Epub 2017 Sep 21. Review. No abstract available.

PMID:
28942897
19.

Stem cell biology and regenerative medicine for neonatal lung diseases.

Kang M, Thébaud B.

Pediatr Res. 2018 Jan;83(1-2):291-297. doi: 10.1038/pr.2017.232. Epub 2017 Oct 18. Review.

PMID:
28922348
20.

Bronchopulmonary Dysplasia: Where Have All the Stem Cells Gone?: Origin and (Potential) Function of Resident Lung Stem Cells.

Möbius MA, Thébaud B.

Chest. 2017 Nov;152(5):1043-1052. doi: 10.1016/j.chest.2017.04.173. Epub 2017 May 4. Review.

PMID:
28479114

Supplemental Content

Loading ...
Support Center